Current challenges in Barrett's esophagus

Barrett's esophagus, a risk factor for esophageal adenocarcinoma, often goe s undetected because it has no defining symptoms that distinguish it from g astroesophageal reflux disease (GERD). Yet early recognition is crucial, an d development of reliable, cost-effective surveillance methods must be a pu blic health priority. Several promising techniques could lead to more effec tive prevention, identification, and management of this premalignant lesion .